Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure

Heart

Volumn 78, Issue 1, 1997, Pages 39-43

  Anker, Stefan D ^a   Leyva, Francisco ^a   Poole Wilson, Philip A ^a   Kox, Wolfgang J ^b   Stevenson, John C ^a   Coats, Andrew J S ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Blood flow; Chronic heart failure; Uric acid; Xanthine oxidase

Indexed keywords

XANTHINE OXIDASE;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CREATININE BLOOD LEVEL; EXERCISE TEST; FEMALE; HUMAN; HYPERURICEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIMB BLOOD FLOW; MALE; PLETHYSMOGRAPHY; PRIORITY JOURNAL; TREADMILL; URIC ACID BLOOD LEVEL;

EID: 0030740687     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.78.1.39     Document Type: Article

References (45)

1. Zelis R, Fleim S. Alterations in vasomotor tone in congestive heart failure. Prog Cardiovasc Dis 1968;24:437 59.
2. Sullivan M, Knight J, Higginbotham M, Cobb F. Relation between central and peripheral hemodynamics during exercise in patients with chronic heart failure. Muscle blood flow is reduced with maintenance of arterial perfusion pressure. Circulation 1989;80:769 81.
3. Zelis R, Mason D, Braunwald E. A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive-heart failure. J Clin Invest 1968;47:960 70.
4. LeJemtel T, Maskin C, Lucido D, Chadwick B. Failure to augment maximal limb blood flow in response to one-leg versus two-leg exercise in patients with severe heart failure. Circulation 1986;74:245 51.
5. Piepoli M, Clark A, Volterrani M, et al. Muscle ergoreflex role in exertional dyspnoea in chronic heart failure patients [abstract]. J Am Coll Cardiol 1989;21:480A.
6. Friedl HP, Smith DJ, Till GO, Thomson PD, Louis DS, Ward PA. Ischemia-reperfusion in humans. Appearance of xanthine oxidase activity. Am J Pathol 1990; 136: 491 5.
7. Lowe G, Fowkes F, Dawes J, Donnan P, Lennie S, Housley E. Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study. Circulation 1993;87:1915-20.
8. Huizer T, de Jong J, Nelson J, et al. Urate production by human heart. J Mol Cell Cardiol 1989;21:691 5.
9. Snoeckx L, van der Vusse G, Coumans W, Willemsen P, Reneman R. Differences in ischaemia tolerance between the postischaemic functional and biochemical recovery of adult and aged hypertrophied hearts. Cardiovasc Res 1993;27:874 81.
10. Lazzarino G, Raatkainen P, Nuutinen M, et al. Myocardial release of malondialdehyde and purine compounds during coronary bypass surgery. Circulation 1994;90:291 7.
11. Swan JW, Walton C, Godsland IF, Clark AL, Coats AJS, Oliver MF. Insulin resistance in heart failure. Eur Heart J 1994;15:1528 32.
12. Carlsen J, Kober L, Torp-Pedersen C, Johansen P. Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects. BMJ 1990;300:975-8.
13. Grahame R, Scott J. Clinical survey of 354 patients with gout. Ann Rheum Dis 1970;29:461-8.
14. Facchini F, Chen Y, Hollenbeck C, Reaven G. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance and plasma uric acid concentration. JAMA 1991;266:3008-11.
15. Modan M, Halkin H, Karasik A, Lusky A. Elevated serum uric acid a facet of hyperinsulinaemia. Diabetologia 1987;30:713 18.
16. Volterrani M, Clark A, Ludman P, et al. Predictors of exercise capacity in chronic heart failure. Eur Heart J 1994; 15:801 9.
17. Trinder P. Determination of blood glucose using an oxidase-peroxidase system with non-carcinogenic chromogen. J Clin Path 1969;22:158-61.
18. Albano JDM, Ekins RP, Maritz G, Turner RC. A sensitive, precise radioimmunoassay of serum insulin relying on charcoal separation of bound and free hormone moieties. Acta Endocrinol 1972;70:487-509.
19. Gochman N, Schmitz J. Automated determination of uric acid using a uricase-peroxidase method. Clin Chem 1971; 17:1154-9.
20. Bergman RN, Ider YZ, Bowden CR, Cobelli C. Quantitative estimation of insulin sensitivity. Am J Physiol 1979;236:E667-77.
21. Leyva F, Anker S, Swan J, et al. Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure. Eur Heart J 1997;18:858-65.
22. Braghiroli A, Sacco C, Erbetta M, Ruga V, Donner C. Overnight urinary acid:creatinine ratio for the detection of sleep hypoxemia. Validation study in chronic obstructive pulmonary disease and obstructive sleep apnea before and after treatment with nasal continuous positive airway pressure. Am Rev Respir Dis 1993;148:173-8.
23. Hasday J, Grum C. Nocturnal increase of urinary uric acid:creatinine ratio. A biochemical correlate of sleep-associated hypoxemia. Am Rev Respir Dis 1987;135: 534-8.
24. Porter KB, O'Brien WF, Benoit R. Comparison of cord purine metabolites to maternal and neonatal variables of hypoxia. Obstet Gynecol 1992;79:394-7.
25. Saugstad OD. Hypoxanthine as a measurement of hypoxia. Pediatr Res 1975;9:158-61.
26. Hayabuchi Y, Matsuoka S, Akita H, Kuroda Y. Hyperuricaemia in cyanotic congenital heart disease. Eur J Pediatr 1993;152:873-6.
27. Ashraf M, Samra Z. Subcellular distribution of xanthine oxidase during cardiac ischaemia and reperfusion: an immunocytochemical study. J Submicrosc Cytol Pathol 1993;25:293-301.
28. Mathru M, Dries DJ, Barnes L, Tonino P, Sukhani R, Rooney MW. Tourniquet-induced exsanguination in patients requiring lower limb surgery. An ischemia-reperfusion model of oxidant and antioxidant metabolism. Anesthesiology 1996;84:14-22.
29. Franciosa J, Park M, Levine T. Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. Am J Cardiol 1981;47:33-9.
30. Lipkin D, Poole-Wilson P. Symptoms limiting exercise capacity in chronic heart failure. BMJ 1986;292:653-5.
31. Grum C, Ketai L, Myers C, Shlafer M. Purine efflux after cardiac ischaemia: relevance to allopurinol cardioprotection. Am J Physiol 1987;252:368-73.
32. Montor S, Thoolen M, Mckin W, Timmermans P. Effect of azapropazone and allopurinol on myocardial infarct size in rats. Eur J Pharmacol 1987;140:203-7.
33. Bolli R. Oxygen-derived free radicals and postischaemic myocardial dysfunction ("stunned myocardium"). J Am Coll Cardiol 1988;12:239-49.
34. Tabayashi K, Suzuki Y, Nagamine S, Ito Y, Sekino Y, Mohri H. A clinical trial of allopurinol (Zyloric) for myocardial protection. J Thorac Cardiovasc Surg 1991; 101:713-8.
35. Zweier J, Kuppusamy P, Lutty G. Measurement of endothelial cell free radical generation: evidence for a central mechanism of free radical injury in post-ischaemic tissues. Proc Natl Acad Sci USA 1988;85:4046-50.
36. Sobey C, Dalipram R, Wodman O. Allopurinol and amlodipine improve coronary vasodilation after myocardial ischaemia and reperfusion in anaesthetised dogs. Br J Pharmacol 1993;108:342-7.
37. Sobey C, Dalipram R, Dusting G, Woodman O. Impaired endothelium-dependent relaxation of dog coronary arteries after myocardial ischaemia and reperfusion: prevention by amlodipine, propranolol and allopurinol. Br J Pharmacol 1992;105:557-62.
38. Tesfamariam B, Cohen R. Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol 1992;263:H321-6.
39. Lindsay D, Holdright D, Clarke D, Anand I, Poole-Wilson P, Collins P. Endothelial control of lower limb blood flow in chronic heart failure. Heart 1996;75:469-76.
40. Ramsey M, Goodfellow J, Jones C, Luddington L, Lewis M, Henderson A. Endothelial control of arterial distensibility is impaired in chronic heart failure. Circulation 1995;92:3212-19.
41. Fakahori M, Ichimori K, Ishida H, Nakagawa H, Okino H. Nitric oxide reversibly suppresses xanthine oxidase activity. Free Radic Res 1994;21:203-12.
42. Rinaldo J, Clark M, Parinello J, Shepherd V. Nitric oxide inactivates xanthine oxidase dehydrogenase and xanthine oxidase in interferon-gamma-stimulated macrophages. Am J Respir Cell Mol Biol 1994;11:625-30.
43. Hassoun P, Yu F, Zulueta J, White A, Lanzillo J. Effect of nitric oxide and cell redox status on the regulation of endothelial cell xanthine dehydrogenase. Am J Physiol 1995;268:pL809-17.
44. Haddad I, Crow J, Hu P, Ye Y, Beckman J, Matalon S. Concurrent generation of nitric oxide and superoxide damages surfactant protein A. Am J Physiol 1994;267: pL242-9.
45. Miyamoto Y, Akaike T, Yoshida M, Goto S, Horie H, Maeda H. Potentiation of nitric oxide-mediated vasorelaxation by xanthine oxidase inhibitors. Proc Soc Exp Biol Med 1996;211:366-73.